To treat his cancer, our reporter David Armstrong takes a drug that costs nearly $1,000 per pill.
The price of the drug, Revlimid, has gone up 26 times since 2006 — yet according to a deposition Armstrong found, a top executive admitted it has always cost just 25 cents to make.